1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Therapy Analysis & Statistics in Norway, May 2017

Therapy Analysis & Statistics in Norway, May 2017

1-15 of 15 reports

Purchase Reports From Reputable Market Research Publishers

2017 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging Opport

  • $ 2450
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Norway

2017 Norway Immunodiagnostics Market: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, TDM, and Tumor Marker Tests--Competitive Strategies, Opportunities

  • $ 2450
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Norway

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

  • $ 1700
  • Industry report
  • March 2017
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Therapy, Pharmaceutical, Healthcare
  • Countries : Norway

Solon Eiendom ASA

  • $ 99
  • Company report
  • May 2017
  • by Wright Investors' Service

A textual analysis of the financial results for Solon Eiendom ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Countries : Norway, United States, World

Algeta ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Therapy
  • Countries : Norway, United Kingdom

Nordic Mining ASA (NOM) - Company Capsule, Timetric

  • $ 99
  • Company report
  • May 2016
  • by Timetric

Synopsis Timetric's "Nordic Mining ASA (NOM) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products ...

  • Industries : Metals, Therapy
  • Countries : Norway

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

  • $ 2450
  • Industry report
  • May 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Therapy
  • Countries : Norway

KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway

Targovax AS - Product Pipeline Review - 2015

  • $ 1500
  • Company report
  • December 2015
  • by Global Markets Direct

Targovax AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Targovax AS - Product Pipeline Review - 2015’, provides an overview of the Targovax AS’s pharmaceutical research and ...

  • Industries : Research and Development, Therapy, Biological Therapy
  • Countries : World, Norway, United States

Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in Norway. ...

  • Industries : Therapy
  • Countries : Norway

Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • $ 652
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Therapy
  • Countries : Norway

Nordic Mining ASA (NOM) - Company Capsule

  • $ 75
  • Company report
  • July 2015
  • by World Market Intelligence Ltd

Synopsis World Market Intelligence's "Nordic Mining ASA (NOM) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key ...

  • Industries : Therapy, Mineral
  • Countries : Norway

PCI Biotech AS - Product Pipeline Review - 2015

  • $ 1500
  • Company report
  • July 2015
  • by Global Markets Direct

PCI Biotech AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘PCI Biotech AS - Product Pipeline Review - 2015’, provides an overview of the PCI Biotech AS’s pharmaceutical research ...

  • Industries : Biotechnology, Cancer, Pathology
  • Countries : Norway

Physician Views: Will patient switching studies support biosimilar adoption?

  • $ 612
  • Industry report
  • June 2015
  • by Firstword Pharma

Europe's first biosimilar monoclonal antibody – Celltrion and Hospira's biosimilar Remicade product Inflectra/Remsima – is approaching its second year anniversary, following approval in the second ...

  • Industries : Biopharmaceutical, Generic Drug
  • Countries : Norway

BerGenBio AS - Product Pipeline Review - 2015

  • $ 1500
  • Company report
  • May 2015
  • by Global Markets Direct

BerGenBio AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘BerGenBio AS - Product Pipeline Review - 2015’, provides an overview of the BerGenBio AS’s pharmaceutical research ...

  • Industries : Research and Development
  • Countries : Norway, World


About 200 reports

Download Unlimited Documents from Trusted Public Sources

Weifa - Quarterly Report, April 2017

  • April 2017
    26 pages
  • Biguanide  

    Opioid  

    Analgesic  

  • Norway  

    World  

View report >

Opioid Market

September 2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.